CPC Main Group
C07D 457/00 Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: [IMAGE cpc-sch-C07D-0988.gif] , e.g. lysergic acid (compounds of the cyclic peptide type derived from ergotamane C07D519/02)
4 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C07D 457/02 with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
- C07D 457/04 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D 457/10 with hetero atoms directly attached in position 8
- C07D 457/14 containing indolo [4, 3-f, g] quinoline ring systems condensed with carbocyclic rings or ring systems
Top Applicants
Top 10 applicants by patent filingsfor class C07, 2013–2023, worldwide · Source: EPO PATSTAT
- ROCHE CH 12,683
- NOVARTIS CH 10,775
- CHINESE ACADEMY OF SCIENCES 10,619
- BASF (BADISCHE ANILIN & SODA FABRIK) DE 9,511
- REGENERON PHARMACEUTICALS US 8,426
- BRISTOL-MYERS SQUIBB COMPANY US 7,979
- LG CHEM KR 7,978
- HARVARD UNIVERSITY US 7,706
- UNIVERSITY OF CALIFORNIA US 7,455
- SINOPEC (CHINA PETROCHEMICAL CORPORATION) 7,219